MIM
SRRA

MetLife Investment Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

MetLife Investment Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,752
Closed -$426K – 2887
2022
Q2 		$426K Buy
+7,752
New +$407K ﹤0.01% 1776

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

MetLife Investment Management's SRRA Position: Q3 2022 in Review

MetLife Investment Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 7,752 shares — an estimated $426K sold.

MetLife Investment Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $426K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • MetLife Investment Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • MetLife Investment Management sold 7,752 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $426K.
  • MetLife Investment Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • MetLife Investment Management's Sierra Oncology, Inc. Common Stock position peaked at $426K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.